Stockreport

Climb Bio to Present at Upcoming Investor Conferences

Climb Bio, Inc.  (CLYM) 
PDF WELLESLEY HILLS, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical stage biotechnology company developing therapeutics for patients w [Read more]